‘Nudging’ both patients and providers boosts flu vaccine numbers
Patients were 28 percent more likely to get a flu shot when they got a text message reminder and their primary care provider already had an order for the shot… read more.
Patients were 28 percent more likely to get a flu shot when they got a text message reminder and their primary care provider already had an order for the shot… read more.
There has been a lasting and disproportionate impact of the Covid-19 pandemic on diagnosis rates for conditions including depression, asthma and osteoporosis. Depression is the most severely impacted,… read more.
Anne Neilan, MD, MPH, of the Medical Practice Evaluation Center (MPEC) and Department of Medicine at Mass General Brigham, and Kevin Ard, MD, MPH, also of the Department of Medicine, are the lead… read more.
Though the U.S. population is aging, nursing home capacity has declined nationwide since the COVID-19 pandemic began. According to a study published in JAMA Internal Medicine this week, one quarter… read more.
A study of adults diagnosed with mpox between May 2022 and January 2023 reveals that over half of the subjects diagnosed with mpox during the 2022 outbreak had… read more.
Adolescents with Human Immunodeficiency Virus (HIV) in Botswana, South Africa, Thailand, Uganda and the United States who received the injectable intramuscular antiviral medications cabotegravir and rilpivirine for nearly… read more.
Shionogi & Co. Ltd. announced that its group company, Shionogi China Co., Ltd, has received approval from the National Medical Products Administration (NMPA) of China for cefiderocol for… read more.
Most COVID-19 vaccine hesitancy is rooted in concerns that can be addressed and effectively reduced over time, according to a new study following more than 1.1 million people… read more.
Flu infections are rising sharply across the United States, contributing to at least 81,000 hospitalizations and 3,100 deaths so far this season, according to the U. S. Centers for… read more.
The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending a change to the terms of the marketing authorisation for Dovprela. (pretomanid). The marketing… read more.
Researchers report that once-weekly treatment with islatravir plus lenacapavir (ISL+LEN) in virologically suppressed adults with HIV has safely maintained high rates of virologic suppression through 48 weeks. The… read more.
Multiple pre-exposure (PrEP) and postexposure (PEP) treatments are now available to prevent HIV infection. An updated Canadian guideline published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.250511 contains 31 recommendations and 10 good practice… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.